QQ客服 官方微博 反馈留言

	Anthelmintic niclosamide suppresses transcription of BCR-ABL fusion oncogene via disabling Sp1 and induces apoptosis in imatinib-resistant CML cells harboring T315I mutant
	Jin, Bei[1,2]; Wang, Chengyan[3]; Shen, Yingying[3]; Pan, Jingxuan[1,2,4]
	2018
卷号	9
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4487032
专题	暨南大学
作者单位	1.[1]Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou, Guangdong, Peoples R China 2.[2]Sun Yat Sen Univ, Guangdong Prov Key Lab Brain Funct & Dis, Guangzhou, Guangdong, Peoples R China 3.[3]Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China 4.[4]Jinan Univ, Inst Tumor Pharmacol, Coll Pharm, Guangzhou, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Jin, Bei[1,2],Wang, Chengyan[3],Shen, Yingying[3],et al. Anthelmintic niclosamide suppresses transcription of BCR-ABL fusion oncogene via disabling Sp1 and induces apoptosis in imatinib-resistant CML cells harboring T315I mutant[J],2018,9.
APA	Jin, Bei[1,2],Wang, Chengyan[3],Shen, Yingying[3],&Pan, Jingxuan[1,2,4].(2018).Anthelmintic niclosamide suppresses transcription of BCR-ABL fusion oncogene via disabling Sp1 and induces apoptosis in imatinib-resistant CML cells harboring T315I mutant.,9.
MLA	Jin, Bei[1,2],et al."Anthelmintic niclosamide suppresses transcription of BCR-ABL fusion oncogene via disabling Sp1 and induces apoptosis in imatinib-resistant CML cells harboring T315I mutant".9(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。